Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-10

Clinical Trial Update: Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care [Phase 4]

View source ↗

Summary

This Phase 4 trial compares OCT and visual acuity outcomes after cataract surgery for patients receiving Xibrom ophthalmic solution with standard presurgical ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone Acetate 1% (prednisolone acetate)
  • Xibrom Ophthalmic Solution (bromfenac ophthalmic solution)

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Cataracts | Phase 4 | Status: COMPLETED